26 related articles for article (PubMed ID: 30274640)
1. Impact of hospital nephrectomy volume on intermediate- to long-term survival in renal cell carcinoma.
Hsu RCJ; Barclay M; Loughran MA; Lyratzopoulos G; Gnanapragasam VJ; Armitage JN
BJU Int; 2020 Jan; 125(1):56-63. PubMed ID: 31206987
[TBL] [Abstract][Full Text] [Related]
2. The impact of histology on survival for patients with metastatic renal cell carcinoma undergoing cytoreductive nephrectomy.
Carrasco A; Thompson RH; Leibovich BC; Lohse CM; Cheville JC; Boorjian SA
Indian J Urol; 2014 Jan; 30(1):38-42. PubMed ID: 24497680
[TBL] [Abstract][Full Text] [Related]
3. Cytoreductive nephrectomy in the era of immune checkpoint inhibitors: a U.S. FDA pooled analysis.
Fallah J; Gittleman H; Weinstock C; Chang E; Agrawal S; Tang S; Pazdur R; Kluetz PG; Suzman DL; Amiri-Kordestani L
J Natl Cancer Inst; 2024 Mar; ():. PubMed ID: 38486364
[TBL] [Abstract][Full Text] [Related]
4. Regionalization of esophagectomy: where are we now?
Clark JM; Boffa DJ; Meguid RA; Brown LM; Cooke DT
J Thorac Dis; 2019 Aug; 11(Suppl 12):S1633-S1642. PubMed ID: 31489231
[TBL] [Abstract][Full Text] [Related]
5. Prognostic effect of cytoreductive nephrectomy in synchronous metastatic renal cell carcinoma: a comparative study using inverse probability of treatment weighting.
Klatte T; Fife K; Welsh SJ; Sachdeva M; Armitage JN; 'Aho T; Riddick AC; Matakidou A; Eisen T; Stewart GD
World J Urol; 2018 Mar; 36(3):417-425. PubMed ID: 29256020
[TBL] [Abstract][Full Text] [Related]
6. Cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium.
Heng DY; Wells JC; Rini BI; Beuselinck B; Lee JL; Knox JJ; Bjarnason GA; Pal SK; Kollmannsberger CK; Yuasa T; Srinivas S; Donskov F; Bamias A; Wood LA; Ernst DS; Agarwal N; Vaishampayan UN; Rha SY; Kim JJ; Choueiri TK
Eur Urol; 2014 Oct; 66(4):704-10. PubMed ID: 24931622
[TBL] [Abstract][Full Text] [Related]
7. Hospital volume and short-term outcomes after cytoreductive nephrectomy.
Xia L; Strother MC; Taylor BL; Chelluri RR; Pulido JE; Guzzo TJ
J Surg Oncol; 2018 Jun; 117(7):1589-1596. PubMed ID: 29575038
[TBL] [Abstract][Full Text] [Related]
8. Comparative Effectiveness of Initial Surgery vs Initial Systemic Therapy for Metastatic Kidney Cancer in the Targeted Therapy Era: Analysis of a Population-based Cohort.
Macleod LC; Odisho AY; Tykodi SS; Holt SK; Harper JD; Gore JL
Urology; 2018 Mar; 113():146-152. PubMed ID: 29174942
[TBL] [Abstract][Full Text] [Related]
9. Benefit from cytoreductive nephrectomy and the prognostic role of neutrophil-to-lymphocyte ratio in patients with metastatic renal cell carcinoma.
Day D; Kanjanapan Y; Kwan E; Yip D; Lawrentschuk N; Davis ID; Azad AA; Wong S; Rosenthal M; Gibbs P; Tran B
Intern Med J; 2016 Nov; 46(11):1291-1297. PubMed ID: 27507629
[TBL] [Abstract][Full Text] [Related]
10. Investigating the effect of treatment at high-volume hospitals on overall survival following cytoreductive nephrectomy.
Berg S; Cole AP; Fletcher SA; Pucheril D; Nabi J; Lipsitz SR; Chang SL; Sun M; Noldus J; Harshman LC; Choueiri TK; Trinh QD
Urol Oncol; 2018 Sep; 36(9):400.e15-400.e22. PubMed ID: 30274640
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of cytoreductive nephrectomy combined with targeted therapy for metastatic renal cell carcinoma: a meta-analysis.
Hong X; Li F; Tang K; Pang S; Lin G; Li S; Bao J; Tan W
Int Urol Nephrol; 2016 Jun; 48(6):967-75. PubMed ID: 26861063
[TBL] [Abstract][Full Text] [Related]
12. Surgical intervention in patients with metastatic renal cancer: metastasectomy and cytoreductive nephrectomy.
Russo P; O'Brien MF
Urol Clin North Am; 2008 Nov; 35(4):679-86; viii. PubMed ID: 18992621
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]